Annals of Hematology

, Volume 84, Issue 8, pp 498–505 | Cite as

Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification

Original Article

Abstract

As cardiac involvement by malignant lymphoma (ML) is relatively uncommon and antemortem diagnosis is difficult, details of this condition remain to be elucidated. To clarify clinicopathologic features of cardiac lymphoma (CL), 25 autopsy cases were studied. Each was rediagnosed according to the World Health Organization (WHO) classification, and clinicopathologic characteristics were investigated by tumor phenotype. The study subjects were 13 males and 12 females with a mean age of 53.4 years. All cases were secondary CL and were not diagnosed as CL before death; 14 cases (56%) were of B-cell and 11 (44%) of T-cell (including natural killer cell) phenotype. Nasal and nasal-type natural killer/T-cell lymphomas (NKTLs) accounted for five (20%). Cardiac manifestation was evident in eight (32%), with hematogenous infiltration as the most common pattern of tumor spread. Some B-cell CLs (n=3) were complicated by cardiac tamponade and heart failure (HF), and T-cell CLs (n=5), including three nasal NKTLs, also featured arrhythmia and sudden death. The incidence of T-cell phenotype was significantly elevated for CLs (p<0.05), especially for CLs with cardiac manifestation (p<0.01), compared with that for MLs in general. Our results indicate that T-cell lymphomas, compared with B-cell lymphomas, invade the heart more frequently and aggressively and are associated with a variety of cardiac manifestations. Where cardiac involvement is suspected, aggressive diagnostic procedures are warranted, especially with MLs having a T-cell phenotype. In cases of nasal NKTL, particular attention is necessary.

Keywords

Malignant lymphoma Heart WHO classification Autopsy 

References

  1. 1.
    Burke A, Virmani R (1996) Tumors of the heart and great vessels. In: Atlas of tumor pathology (third series, fascicle 16). Armed Forces Institute of Pathology, Washington DC, pp 171–179Google Scholar
  2. 2.
    Ceresoli GL, Ferreri AJM, Bucci E, Ripa C, Ponzoni M, Villa E (1997) Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer 80:1497–1506CrossRefPubMedGoogle Scholar
  3. 3.
    Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PTM, Ng CS, Ngan RKC (1998) Primary non-Hodgkin’s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70–77Google Scholar
  4. 4.
    Chinen K, Kaneko Y, Izumo T, Ohkura Y, Matsubara O, Tsuchiya E (2002) Nasal natural killer cell/T-cell lymphoma showing cellular morphology mimicking normal lymphocytes. Arch Pathol Lab Med 126:602–605Google Scholar
  5. 5.
    Chou S-T, Arkles LB, Gill GD, Pinkus N, Parkin A, Hicks JD (1983) Primary lymphoma of the heart: a case report. Cancer 52:744–747Google Scholar
  6. 6.
    Curtsinger CR, Wilson MJ, Yoneda K (1989) Primary cardiac lymphoma. Cancer 64:521–525PubMedGoogle Scholar
  7. 7.
    Daisley H, Charles W (1997) Cardiac involvement with lymphoma/leukemia: a report of three autopsy cases. Leukemia 11 [Suppl 3]:522–524Google Scholar
  8. 8.
    Fava C, Ghidoni P, Broich G, Matturri L (1998) Cardiac malignant lymphoma: a case report. Anticancer Res 18:1291–1294Google Scholar
  9. 9.
    Furihata M, Ido E, Iwata J, Sonobe H, Ohtsuki Y, Takata J, Chikamori T, Doi Y (1998) Adult T cell leukemia/lymphoma with massive involvement of cardiac muscle and valves. Pathol Int 48:221–224Google Scholar
  10. 10.
    Gabarre J, Gessain A, Raphael M, Merle-Beral H, Dubourg O, Fourcade C, Gandjbakhch I, Jault F, Delcourt A, Binet J-L (1993) Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lymphomatous involvement in an Iranian woman: clinical, immunopathological and viromolecular studies. Leukemia 7:1904–1909Google Scholar
  11. 11.
    Gill PS, Chandraratna PAN, Meyer PR, Levine AM (1987) Malignant lymphoma: cardiac involvement at initial presentation. J Clin Oncol 5:216–224Google Scholar
  12. 12.
    Holladay AO, Siegel RJ, Schwartz DA (1992) Cardiac malignant lymphoma in acquired immune deficiency syndrome. Cancer 70:2203–2207Google Scholar
  13. 13.
    Iemura A, Yano H, Kojiro M, Nouno R, Kouno K (1991) Massive cardiac involvement of adult T-cell leukemia/lymphoma: an autopsy case. Arch Pathol Lab Med 115:1052–1054Google Scholar
  14. 14.
    Iqbal Y, Al-Sudairy R, Abdullah MF, Al-Omari A, Crankson S (2003) Non-Hodgkin lymphoma manifesting as thyroid nodules and cardiac involvement. J Pediatr Hematol Oncol 25:987–988Google Scholar
  15. 15.
    Izumo T, Maseki N, Mori S, Tsuchiya E (2000) Practical utility of the revised European–American classification of lymphoid neoplasms for Japanese non-Hodgkin’s lymphomas. Jpn J Cancer Res 91:351–360Google Scholar
  16. 16.
    Jaffe ES, Chan JKC, Su I-J, Frizzera G, Mori S, Feller AC, Ho FCS (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103–111Google Scholar
  17. 17.
    Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC, LyonGoogle Scholar
  18. 18.
    Kikuchi M, Takeshita M, Ohshima K, Yoshida T (1992) Pathology of adult T-cell leukemia/lymphoma and HTLV-1 associated organopathies. Gann Monogr Cancer Res 39:69–80Google Scholar
  19. 19.
    Kuwabara H, Tsuji M, Yoshii Y, Kakuno Y, Akioka T, Kotani T, Iwao N, Hanafusa T, Ikeda T, Mori H (2003) Nasal-type NK/T cell lymphoma of the orbit with distant metastases. Hum Pathol 34:290–292Google Scholar
  20. 20.
    Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengarner H, Podack ER (1988) Structure and function of human perforin. Nature 335:448–451CrossRefPubMedGoogle Scholar
  21. 21.
    Liedtke AJ, Adams DF, Weber ET, Gorlin R (1971) Remission of cardiac lymphoma with supervoltage radiation. Am J Med 50:816–822Google Scholar
  22. 22.
    Liu C-C, Walsh CM, Young JD-E (1995) Perforin: structure and function. Immunol Today 16:194–201CrossRefPubMedGoogle Scholar
  23. 23.
    Lymphoma Study Group of Japanese Pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696–702Google Scholar
  24. 24.
    Madianos M, Sokal JE (1963) Cardiac involvement in lymphosarcoma and reticulum cell sarcoma. Am Heart J 65: 322–326Google Scholar
  25. 25.
    McDonnell PJ, Mann RB, Bulkley BH (1982) Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer 49:944–951Google Scholar
  26. 26.
    Nand S, Mullen GM, Lonchyna VA, Moncada R (1991) Primary lymphoma of the heart: prolonged survival with early systemic therapy in a patient. Cancer 68:2289–2292Google Scholar
  27. 27.
    Petersen CD, Robinson WA, Kurnick JE (1976) Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci 272:161–165Google Scholar
  28. 28.
    Roberts WC, Glancy DL, DeVita VT (1968) Heart in malignant lymphoma (Hodgkin’s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides): a study of 196 autopsy cases. Am J Cardiol 22:85–107Google Scholar
  29. 29.
    Sato E, Hasui K, Tokunaga M (1982) Autopsy findings of adult T cell lymphoma-leukemia. Gann Monogr Cancer Res 28:51–64Google Scholar
  30. 30.
    Sato H, Takahashi M (1993) Non-Hodgkin’s malignant lymphoma of the bone with intracavitary cardiac involvement. Intern Med 32:502–507Google Scholar
  31. 31.
    Schulz L, Twite M, Liang X, Lovell M, Stork L (2004) A case of childhood peripheral T-cell lymphoma with massive cardiac infiltration. J Pediatr Hematol Oncol 26:48–51Google Scholar
  32. 32.
    Servitje O, Limon A, Blanco A, Carmona M, Serrano T, Romagosa V, Gallardo F, Garcia J, Peyri J (1999) Cardiac involvement and molecular staging in a fatal case of mycosis fungoides. Br J Dermatol 141:531–535Google Scholar
  33. 33.
    Smyth MJ, Trapani JA (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202–206Google Scholar
  34. 34.
    Terry LN, Kligerman MM (1970) Pericardial and myocardial involvement by lymphomas and leukemias: the role of radiotherapy. Cancer 25:1003–1008Google Scholar
  35. 35.
    Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC (1992) CD56 (NKH1)-positive hamatolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 23:798–804Google Scholar
  36. 36.
    Yamashita Y, Yatabe Y, Tsuzuki T, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T, Mori N (1998) Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 11:313–323PubMedGoogle Scholar
  37. 37.
    Zelger BG, Zelger BWH, Konwalinka G, Mikuz G, Fend F (1997) Non-Hodgkin lymphoma with exclusive involvement of the heart and the gastrointestinal tract. Virchows Arch 430:427–430Google Scholar
  38. 38.
    Zocchi MR, Poggi A (1995) Human γδT lymphocytes use N-CAM to interact with the subendothelial matrix. J Natl Cancer Inst 87:846–847Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Department of PathologyKyorin University School of MedicineTokyoJapan
  2. 2.Department of PathologySaitama Cancer CenterSaitamaJapan

Personalised recommendations